WEKO3
アイテム
{"_buckets": {"deposit": "28666851-fbbd-4e03-bba7-ed988f115592"}, "_deposit": {"created_by": 1, "id": "86447", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "86447"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00086447", "sets": ["28"]}, "author_link": ["1055061", "1055064", "1055066", "1055057", "1055058", "1055063", "1055065", "1055060", "1055062", "1055067", "1055059"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2022-06-11", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Purpose/Background:\nThe orexin 2 receptor (OX2R) is a G-protein coupled receptor expressed in brain that binds orexin neuropeptides A and B. OX2R is involved in motivation, feeding behaviour, and sleep-wake regulation. Modulation of OX2R with agonists has been found to be a potential treatment towards sleep related disorders. Herein we report [11C]1 and [11C]2 as novel and potential PET ligands for imaging orexin 2 receptor and explore their applications in small animals.\n\nMethods:\nCompounds 1 and 2 were prepared according to a published patent.1 The phenolic precursors were synthesized via demethylation of compounds 1 and 2. The radiosynthesis of [11C]1 and [11C]2 were performed by 11C-methylation of phenolic precursors with [11C]CH3I and Cs2CO3 as the base in DMF at 80 oC for 5 min. The in vitro autoradiography was performed with [11C]1 and [11C]2 on Sprague Dawley rat brain slices. Dynamic PET imaging studies with [11C]1 and [11C]2 were carried out on Sprague Dawley rats with 60 min scans.\n\nResults:\nCompounds 1 (OX2: IC50 = 4 nM, OX1: IC50 \u003e 4000 nM) and 2 (OX2: IC50 = 4 nM, OX1: IC50 \u003e 5000 nM) are selective antagonists at the OX2.1 Compounds 1 and 2 were prepared in 2% and 20% overall yields over four steps, respectively. The phenolic precursors were synthesized via demethylation of compounds 1 and 2 in 41% and 45% yields, respectively. The radiosynthesis of PET ligands [11C]1 and [11C]2 were via 11C-methylation of phenolic precursors with [11C]CH3I and both [11C]1 and [11C]2 were obtained in more than 10% radiochemical yields (decay corrected). Both [11C]1 and [11C]2 had radiochemical purities greater than 99%, and no obvious decompositions of [11C]1 and [11C]2 were found in saline in 90 min. In in vitro autoradiography studies with [11C]1 and [11C]2, high radioactivity accumulation was observed in the hippocampus and cortex. In blocking studies of autoradiography, EMPA (10 μM) rendered diminished radioactivity in OX2R-rich brain regions. In dynamic PET imaging studies with [11C]1, the standard uptake value (SUV) of [11C]1 in hippocampus and cerebellum reached the max value of 0.2 at 2 min and washed out rapidly, and finally reduced to 0.1 at 60 min. PET imaging with [11C]2 showed a similar result. In blocking studies of PET imaging, no significant difference in uptake in the hippocampus and cerebellum was observed for both [11C]1 and [11C]2. Pretreatment with elacridar (3 mg/kg) led to a significant increase of uptake in hippocampus and cerebellum for both [11C]1 and [11C]2.\n\nConclusion:\nWe have developed two novel PET ligand [11C]1 and [11C]2 for imaging OX2R. The PET ligands [11C]1 and [11C]2 were both prepared in more than 10% radiochemical yield (decay corrected). In autoradiography studies, both [11C]1 and [11C]2 showed high binding specificities in hippocampus and cortex in vitro. While in vivo PET imaging with [11C]1 and [11C]2 demonstrated moderate binding affinities towards OX2R, their poor blood-brain barrier permeabilities and rapid clearance from the brain prevent further evaluation. \n", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "SNMMI2022", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Rong, Jian"}], "nameIdentifiers": [{"nameIdentifier": "1055057", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tomoteru, Yamasaki"}], "nameIdentifiers": [{"nameIdentifier": "1055058", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhao, Chunyu"}], "nameIdentifiers": [{"nameIdentifier": "1055059", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Li, Yinlong"}], "nameIdentifiers": [{"nameIdentifier": "1055060", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shao, Yihan"}], "nameIdentifiers": [{"nameIdentifier": "1055061", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhe Sun, Phillip"}], "nameIdentifiers": [{"nameIdentifier": "1055062", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "L. Collier, Thomas"}], "nameIdentifiers": [{"nameIdentifier": "1055063", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong"}], "nameIdentifiers": [{"nameIdentifier": "1055064", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Liang, Steven"}], "nameIdentifiers": [{"nameIdentifier": "1055065", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tomoteru, Yamasaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1055066", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1055067", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Development of Novel PET Ligands for Imaging Orexin 2 Receptor ", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Development of Novel PET Ligands for Imaging Orexin 2 Receptor "}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/86447", "pubdate": {"attribute_name": "公開日", "attribute_value": "2022-06-20"}, "publish_date": "2022-06-20", "publish_status": "0", "recid": "86447", "relation": {}, "relation_version_is_last": true, "title": ["Development of Novel PET Ligands for Imaging Orexin 2 Receptor "], "weko_shared_id": -1}
Development of Novel PET Ligands for Imaging Orexin 2 Receptor
https://repo.qst.go.jp/records/86447
https://repo.qst.go.jp/records/86447f683f10e-5f4c-47f3-9b1f-2be653446e55
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-06-20 | |||||
タイトル | ||||||
タイトル | Development of Novel PET Ligands for Imaging Orexin 2 Receptor | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Rong, Jian
× Rong, Jian× Tomoteru, Yamasaki× Zhao, Chunyu× Li, Yinlong× Shao, Yihan× Zhe Sun, Phillip× L. Collier, Thomas× Zhang, Ming-Rong× Liang, Steven× Tomoteru, Yamasaki× Zhang, Ming-Rong |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose/Background: The orexin 2 receptor (OX2R) is a G-protein coupled receptor expressed in brain that binds orexin neuropeptides A and B. OX2R is involved in motivation, feeding behaviour, and sleep-wake regulation. Modulation of OX2R with agonists has been found to be a potential treatment towards sleep related disorders. Herein we report [11C]1 and [11C]2 as novel and potential PET ligands for imaging orexin 2 receptor and explore their applications in small animals. Methods: Compounds 1 and 2 were prepared according to a published patent.1 The phenolic precursors were synthesized via demethylation of compounds 1 and 2. The radiosynthesis of [11C]1 and [11C]2 were performed by 11C-methylation of phenolic precursors with [11C]CH3I and Cs2CO3 as the base in DMF at 80 oC for 5 min. The in vitro autoradiography was performed with [11C]1 and [11C]2 on Sprague Dawley rat brain slices. Dynamic PET imaging studies with [11C]1 and [11C]2 were carried out on Sprague Dawley rats with 60 min scans. Results: Compounds 1 (OX2: IC50 = 4 nM, OX1: IC50 > 4000 nM) and 2 (OX2: IC50 = 4 nM, OX1: IC50 > 5000 nM) are selective antagonists at the OX2.1 Compounds 1 and 2 were prepared in 2% and 20% overall yields over four steps, respectively. The phenolic precursors were synthesized via demethylation of compounds 1 and 2 in 41% and 45% yields, respectively. The radiosynthesis of PET ligands [11C]1 and [11C]2 were via 11C-methylation of phenolic precursors with [11C]CH3I and both [11C]1 and [11C]2 were obtained in more than 10% radiochemical yields (decay corrected). Both [11C]1 and [11C]2 had radiochemical purities greater than 99%, and no obvious decompositions of [11C]1 and [11C]2 were found in saline in 90 min. In in vitro autoradiography studies with [11C]1 and [11C]2, high radioactivity accumulation was observed in the hippocampus and cortex. In blocking studies of autoradiography, EMPA (10 μM) rendered diminished radioactivity in OX2R-rich brain regions. In dynamic PET imaging studies with [11C]1, the standard uptake value (SUV) of [11C]1 in hippocampus and cerebellum reached the max value of 0.2 at 2 min and washed out rapidly, and finally reduced to 0.1 at 60 min. PET imaging with [11C]2 showed a similar result. In blocking studies of PET imaging, no significant difference in uptake in the hippocampus and cerebellum was observed for both [11C]1 and [11C]2. Pretreatment with elacridar (3 mg/kg) led to a significant increase of uptake in hippocampus and cerebellum for both [11C]1 and [11C]2. Conclusion: We have developed two novel PET ligand [11C]1 and [11C]2 for imaging OX2R. The PET ligands [11C]1 and [11C]2 were both prepared in more than 10% radiochemical yield (decay corrected). In autoradiography studies, both [11C]1 and [11C]2 showed high binding specificities in hippocampus and cortex in vitro. While in vivo PET imaging with [11C]1 and [11C]2 demonstrated moderate binding affinities towards OX2R, their poor blood-brain barrier permeabilities and rapid clearance from the brain prevent further evaluation. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | SNMMI2022 | |||||
発表年月日 | ||||||
日付 | 2022-06-11 | |||||
日付タイプ | Issued |